- Home
- Products
VIVITROL (Naltrexone)
VIVITROL (Naltrexone)
- Medicine Name: Vivitrol
- Generic Name: Naltrexone
- Dosage Form & Strength: Injection: 380 mg per vial
- Manufactured By: Alkermes, Inc
Vivitrol (Naltrexone) is an opioid antagonist used for:
- Treatment of alcohol dependence in patients who have successfully abstained from alcohol in an outpatient setting prior to therapy initiation.
- Prevention of relapse to opioid dependence after opioid detoxification.
It is administered as a monthly intramuscular injection as part of a comprehensive treatment program including psychosocial support.
Do not initiate Vivitrol in patients actively drinking or using opioids.
Ensure the patient is opioid-free before starting treatment to avoid precipitated withdrawal.
Monitor for eosinophilic pneumonia symptoms—discontinue if suspected.
Risk of liver injury—evaluate liver function and discontinue if signs of hepatitis occur.
Use with caution in patients with coagulation disorders or hepatic failure.
Injection site reactions including abscess, cellulitis, or necrosis may occur—monitor closely.
Required Documentation for Import to India
To import Vivitrol 380 mg to India via Named Patient Supply (NPS), the following are required:
- Valid prescription from a qualified physician
- Patient’s diagnostic reports
- Government-issued ID proof
- Import permit (if applicable)
Order is confirmed only after verifying the above.
Availability in India
Vivitrol is a prescription-only medication that can be legally imported to cities across India, including:
- Mumbai, Delhi, Bangalore, Hyderabad, Kolkata, Chennai, Pune, Ahmedabad
- Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Srinagar, Jammu, and more
For availability, best prices, and import guidance:
📞 Call/WhatsApp: +91-9310090915
📧 Email: info@indianpharmanetwork.in
📞 Toll-Free: 1800-889-1064
- Sourced from certified global suppliers in the USA, Canada, Europe, and Australia.
- Dispensed only against valid prescriptions.
- All orders are processed by licensed pharmacists and shipped from New Delhi.
- Global delivery available, with full quality and compliance assurance.
Q: What is the generic name of Vivitrol?
A: Naltrexone.
Q: Who manufactures Vivitrol?
A: Alkermes, Inc.
Q: Is Vivitrol FDA approved?
A: Yes. FDA approval date: 1984.
Q: What form is Vivitrol supplied in?
A: Injectable suspension containing 380 mg naltrexone.
Q: What are the common side effects?
A: Nausea, headache, anxiety, insomnia, and injection site reactions.
Q: How should Vivitrol be stored?
A: Refrigerate between 2°C–8°C. Do not freeze or expose to heat above 25°C.
Q: How can I buy Vivitrol in India?
A: Contact Indian Pharma Network (IPN) at +91-9310090915 or info@indianpharmanetwork.in for cost and availability.
Call to Action
Get Access to Vivitrol in India
Secure your Vivitrol supply legally with full prescription compliance.
👉 Contact Now
📞 +91-9310090915 | Toll-Free 1800-889-1064
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
